Literature DB >> 30713396

The Relationship between Blood Viscosity and Isolated Coronary Artery Ectasia.

Yusuf Çekici1, Salih Kılıç1, Erhan Saraçoğlu1, Mustafa Çetin1, İrfan Veysel Düzen2, Mücahid Yılmaz3.   

Abstract

BACKGROUND: It is unclear whether isolated coronary artery ectasia (iCAE) is associated with whole blood viscosity (WBV). In the present study, we investigated WBV in coronary artery ectasia (CAE) patients.
METHODS: Seventy-eight patients with iCAE and 83 controls with normal coronary arteries were selected from 12290 patients who underwent coronary angiography between January 2014 and December 2017. WBV was calculated with a validated equation from hematocrit and total plasma protein levels for a low (LSR) and high (HSR) shear rate.
RESULTS: Baseline demographic characteristics and medical history of the groups were similar. The mean level of C-reactive protein (2.1 ± 0.53 vs. 1.93 ± 0.44; p = 0.042) and total protein (7.2 ± 0.3 vs. 7.0 ± 0.6; p = 0.009) were significantly higher in the iCAE group than in the control subjects. Both HSR (4.57 ± 0.6 vs. 3.9 ± 0.7; p < 0.001) and LSR (33.5 ± 9.6 vs. 25.1 ± 9.2; p < 0.001) levels were significantly higher in the iCAE group than in the control group. In ROC analysis, a cut-off value of 4.19 WBV for HSR had an 80.8% sensitivity and 72.3% specificity [area under the curve (AUC): 0.779, 95% CI 70.6-85.1; p < 0.001] and a cut-off value of 27.5 WBV for LSR had an 80.1% sensitivity and 72.3% specificity for predicting iCAE (AUC: 0.788, 95% CI 71.4-86.2; p < 0.001). In multivariate analysis, both LSR (p < 0.001, OR 1.10, 95% CI 1.05-1.15) and HSR (p < 0.001, OR 4.60, 95% CI 2.33-9.09) were independent predictors for the presence of iCAE.
CONCLUSIONS: In the present study, we determined that in WBV, both HSR and LSR were significantly higher in the iCAE group than in the control subjects, and that this may be a possible cause of iCAE.

Entities:  

Keywords:  Atherosclerosis; Coronary artery ectasia; Whole blood viscosity

Year:  2019        PMID: 30713396      PMCID: PMC6342839          DOI: 10.6515/ACS.201901_35(1).20180701A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  31 in total

1.  Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study.

Authors:  G Lowe; A Rumley; J Norrie; I Ford; J Shepherd; S Cobbe; P Macfarlane; C Packard
Journal:  Thromb Haemost       Date:  2000-10       Impact factor: 5.249

2.  Aneurysms of the coronary artery. Report of ten cases and review of literature.

Authors:  A S DAOUD; D PANKIN; H TULGAN; R A FLORENTIN
Journal:  Am J Cardiol       Date:  1963-02       Impact factor: 2.778

Review 3.  Blood viscosity and cardiovascular disease.

Authors:  G D Lowe
Journal:  Thromb Haemost       Date:  1992-05-04       Impact factor: 5.249

4.  Is systemic inflammation responsible for coronary artery ectasia?

Authors:  Jian-Jun Li; Jian-Guo He; Jing-Long Nan; Zho-Xiang He; Chen-Gang Zhu; Jie Li
Journal:  Int J Cardiol       Date:  2008-01-22       Impact factor: 4.164

5.  Plasma soluble adhesion molecules; intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin levels in patients with isolated coronary artery ectasia.

Authors:  Hasan Turhan; Ali Riza Erbay; Ayse Saatci Yasar; Yuksel Aksoy; Asuman Bicer; Gulay Yetkin; Ertan Yetkin
Journal:  Coron Artery Dis       Date:  2005-02       Impact factor: 1.439

Review 6.  Clinical significance of coronary arterial ectasia.

Authors:  J E Markis; C D Joffe; P F Cohn; D J Feen; M V Herman; R Gorlin
Journal:  Am J Cardiol       Date:  1976-02       Impact factor: 2.778

Review 7.  Coronary artery aneurysms: a review of the natural history, pathophysiology, and management.

Authors:  Paul Cohen; Patrick T O'Gara
Journal:  Cardiol Rev       Date:  2008 Nov-Dec       Impact factor: 2.644

Review 8.  Coronary artery aneurysm: a review and hypothesis regarding etiology.

Authors:  Larry Nichols; Stephen Lagana; Anil Parwani
Journal:  Arch Pathol Lab Med       Date:  2008-05       Impact factor: 5.534

9.  Adiponectin levels in coronary artery ectasia.

Authors:  Necati Dagli; Unal Ozturk; Ilgin Karaca; Mustafa Yavuzkir; Suleyman Koca; Handan Akbulut; Mehmet Balin
Journal:  Heart Vessels       Date:  2009-03       Impact factor: 2.037

10.  [Atherosclerosis and the role of inflammation].

Authors:  Lale Tokgözoğlu
Journal:  Turk Kardiyol Dern Ars       Date:  2009-04
View more
  5 in total

1.  Association of whole blood viscosity with thrombus presence in patients undergoing transoesophageal echocardiography.

Authors:  Tufan Çınar; Mert İlker Hayıroğlu; Murat Selçuk; Vedat Çiçek; Selami Doğan; Şahhan Kılıç; Samet Yavuz; Mert Babaoğlu; Mehmet Uzun; Ahmet Lütfullah Orhan
Journal:  Int J Cardiovasc Imaging       Date:  2021-10-15       Impact factor: 2.357

Review 2.  Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis.

Authors:  Dimitrios A Vrachatis; Konstantinos A Papathanasiou; Dimitrios Kazantzis; Jorge Sanz-Sánchez; Sotiria G Giotaki; Konstantinos Raisakis; Andreas Kaoukis; Charalampos Kossyvakis; Gerasimos Deftereos; Bernhard Reimers; Dimitrios Avramides; Gerasimos Siasos; Michael Cleman; George Giannopoulos; Alexandra Lansky; Spyridon Deftereos
Journal:  Diagnostics (Basel)       Date:  2022-04-19

3.  Impact of Apelin-13 on the Development of Coronary Artery Ectasia.

Authors:  Xusen Sun; Yufan Zhang; Xin Qi; Liping Wei
Journal:  Acta Cardiol Sin       Date:  2020-05       Impact factor: 2.672

4.  Relationship between Serum Salusin Beta Levels and Coronary Artery Ectasia.

Authors:  Arafat Yildirim; Mehmet Kucukosmanoglu
Journal:  Acta Cardiol Sin       Date:  2021-03       Impact factor: 2.672

5.  Curative Effect of Yangxin Dingji Capsule Combined With Mexiletine Hydrochloride on Postoperative Arrhythmia and Its Influences on the Vascular Endothelial Function in Coronary Bifurcation Lesions.

Authors:  Nasha Sun; Wangkun Chen; Yan Wu; Qiyi Yu; Xia Zhou; Bing Guo
Journal:  Emerg Med Int       Date:  2022-08-30       Impact factor: 1.621

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.